Literature DB >> 8620915

The concurrent prevalence of chloramphenicol-sensitive and multi-drug resistant Salmonella typhi in Vellore, S. India.

M V Jesudason1, R John, T J John.   

Abstract

A multidrug resistant (MDR) variety of Salmonella typhi emerged as the cause of epidemic typhoid fever in some Asian countries including India, during the late 1980s. We faced the epidemic from April 1990 to the first quarter of 1993. However, during this period we continued to isolate chloramphenicol sensitive (CS) S. typhi also. The relative prevalences showed that the frequency of CS variety was unaffected by the epidemic of MDR variety. This is an unusual epidemiological pattern, which indicates that there may have been factors which favoured the epidemic of the MDR variety but not the CS one.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620915      PMCID: PMC2271629          DOI: 10.1017/s095026880005247x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Unusual complications in a multidrug resistant Salmonella typhi outbreak.

Authors:  A Ramanan; N Pandit; M Yeshwanth
Journal:  Indian Pediatr       Date:  1992-01       Impact factor: 1.411

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Clinical profile and outcome in enteric fever.

Authors:  A Sharma; G Gathwala
Journal:  Indian Pediatr       Date:  1993-01       Impact factor: 1.411

4.  An improved technique for blood culture.

Authors:  G Koshi; W Alex; T Menon
Journal:  Indian J Med Res       Date:  1981-05       Impact factor: 2.375

5.  Treatment of typhoid fever with ofloxacin.

Authors:  F Wang; X J Gu; M F Zhang; T Y Tai
Journal:  J Antimicrob Chemother       Date:  1989-05       Impact factor: 5.790

6.  Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi.

Authors:  F W Goldstein; J C Chumpitaz; J M Guevara; B Papadopoulou; J F Acar; J F Vieu
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

7.  Widespread occurrence of multiple drug-resistant Salmonella typhi in India.

Authors:  E J Threlfall; L R Ward; B Rowe; S Raghupathi; V Chandrasekaran; J Vandepitte; P Lemmens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

Review 8.  The appearance & spread of Vibrio cholerae 0139 in India.

Authors:  M V Jesudason; T J John
Journal:  Indian J Med Res       Date:  1994-03       Impact factor: 2.375

  8 in total
  5 in total

1.  Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.

Authors:  M Hussein Gasem; Monique Keuter; Wil M V Dolmans; Johanna Van Der Ven-Jongekrijg; Robert Djokomoeljanto; Jos W M Van Der Meer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India.

Authors:  Shanta Dutta; Dipika Sur; Byomkesh Manna; Sujit K Bhattacharya; Jacqueline L Deen; John D Clemens
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India.

Authors:  P M Shanahan; M V Jesudason; C J Thomson; S G Amyes
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

4.  Antibiogram Profile of Salmonella enterica Serovar Typhi in India - A Two Year Study.

Authors:  Yashwant Kumar; Anshu Sharma; Kavaratty Raju Mani
Journal:  Trop Life Sci Res       Date:  2013-08

5.  Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019.

Authors:  Farah N Qamar; Mohammad T Yousafzai; Irum F Dehraj; Sadia Shakoor; Seema Irfan; Aneeta Hotwani; Muhammad J Hunzai; Rozina S Thobani; Najeeb Rahman; Junaid Mehmood; Caitlin Hemlock; Ashraf M Memon; Jason R Andrews; Stephen P Luby; Denise O Garrett; Ashley T Longley; Kashmira Date; Samir K Saha
Journal:  Clin Infect Dis       Date:  2020-12-01       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.